Delivery Order SPE2DB22D2005-SPE2DB24FJRQ7

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $3,094.85 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets to the Defense Logistics Agency (DLA). The $1,768.34 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of October 15, 2024 and does not utilize a set-aside designation. As a large indefinite delivery vehicle (IDV) contractor with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets in quantities of 100s to the Defense Logistics Agency (DLA). The $3,188.30 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This order is a child of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The $1,334.73 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2025, with a completion date of May 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets in 100-count packages to the Defense Logistics Agency (DLA), a defense agency. The $3,442.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 28, 2025, with an ultimate completion date of May 29, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense. The contract, valued at $1,794.61, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 15, 2021. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA. This IDC, valued at up...
This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets in 100-count packages. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on March 19, 2025. The contract has a ceiling value of $1,056.00 and a completion date of March 20, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets (90 count) to the Defense Logistics Agency (DLA). The $1,148.00 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
This federal contract award is for Methylphenidate ER 54 mg tablets, a prescription medication, awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,557.30 and a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of 100 units of the pharmaceutical product Methylphenidate ER 36 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $1,543.80 and a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRQ7
    Delivery Order

This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $8,299.99 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 21, 2024, with a completion date of August 22, 2024. The contract is not set-aside. AmerisourceBergen has been awarded several Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, to supply a wide range of essential pharmaceutical and medical products to support government healthcare programs and military treatment facilities.

Generated 11/20/24, 9:22 AM